Search - tctmd.com

Displaying 101 - 120 of 260

Sort: Relevancy | Date

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

Wearable Devices Are Cost-effective AF Screening Tools

News Daily News

Wearable Devices Are Cost-effective AF Screening Tools

August 10, 2022

Meat Consumption and Gut Microbiome Linked to ASCVD Risk

News Daily News

Meat Consumption and Gut Microbiome Linked to ASCVD Risk

Yael L. Maxwell

August 03, 2022

AHA Registry IDs Social Vulnerability as Risk Factor for COVID-19 Death

News Daily News

AHA Registry IDs Social Vulnerability as Risk Factor for COVID-19 Death

July 22, 2022

Knowns, Unknowns of Vaccine Myocarditis Risks Summarized in ‘Living’ Review

News Daily News

Knowns, Unknowns of Vaccine Myocarditis Risks Summarized in ‘Living’ Review

July 21, 2022

Increased Blood Viscosity Tied to Mortality in Hospitalized COVID-19 Patients

News Daily News

Increased Blood Viscosity Tied to Mortality in Hospitalized COVID-19 Patients

July 18, 2022

TCTMD’s Top 10 Most Popular Stories for June 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2022

July 04, 2022

COVID-19: TCTMD’s Dispatch for July 2022

News Daily News

COVID-19: TCTMD’s Dispatch for July 2022

July 01, 2022

Political Leanings Found to Affect Mortality Rates Now More Than Ever

News Daily News

Political Leanings Found to Affect Mortality Rates Now More Than Ever

June 17, 2022

COVID-19: TCTMD’s Dispatch for June Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for June Week 3

June 13, 2022

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

June 09, 2022

COVID-19: TCTMD’s Dispatch for June Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for June Week 2

June 06, 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

Few Cardiac Events Seen in College Athletes After COVID-19: ORCCA Registry

News Daily News

Few Cardiac Events Seen in College Athletes After COVID-19: ORCCA Registry

May 20, 2022

Texting Tool Failed to Up Pill Adherence in ACS Patients: TEXTMEDS

News Daily News

Texting Tool Failed to Up Pill Adherence in ACS Patients: TEXTMEDS

May 10, 2022

Good News and Bad for High-Intensity Statin Use in ASCVD

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

Age and Fitness Biggest Predictors of Mortality in CAD Patients, AI Study Shows

News Daily News

Age and Fitness Biggest Predictors of Mortality in CAD Patients, AI Study Shows

Michael O'Riordan

May 04, 2022

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

News Daily News

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Michael O'Riordan

April 27, 2022

Making a Game of Digital Tools Ups Exercise in High-Risk Postpartum Women

News Daily News

Making a Game of Digital Tools Ups Exercise in High-Risk Postpartum Women

April 25, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.